Alvotech
ALVONASDAQHealthcare● Active
$3.94
+$0.40(+11.30%)
Market Cap$1.2B
P/E Ratio—
52W High$11.12
52W Low$2.94
Alvotech（ALVO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALVO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.59B | $0.49B | $0.09B | $0.08B | $0.04B |
| Cost of Revenue | $0.24B | $0.19B | $0.16B | $0.06B | $0.00B |
| Gross Profit | $0.35B | $0.30B | ($0.07B) | $0.02B | $0.04B |
| Gross Margin %(computed) | 59.82% | 62.16% | -75.93% | 22.80% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.18B | $0.17B | $0.21B | $0.18B | $0.19B |
| G&A Expenses | $0.09B | $0.06B | $0.07B | $0.19B | $0.08B |
| Total Operating Expenses | $0.27B | $0.23B | $0.29B | $0.37B | $0.27B |
| Operating Income | $0.08B | $0.07B | ($0.35B) | ($0.35B) | ($0.24B) |
| Operating Margin %(computed) | 13.34% | 14.22% | -388.11% | -417.25% | -640.31% |
| Interest Income | $0.20B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.15B | $0.16B | $0.13B | $0.09B | $0.11B |
| Income Before Tax | $0.14B | ($0.22B) | ($0.65B) | ($0.55B) | ($0.15B) |
| Income Tax Expense | $0.11B | $0.01B | ($0.10B) | ($0.04B) | ($0.05B) |
| Net Income | $0.03B | ($0.23B) | ($0.55B) | ($0.51B) | ($0.10B) |
| Net Margin %(computed) | 4.76% | -47.35% | -603.42% | -618.55% | -276.04% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.10 | $-0.87 | $-2.43 | $-2.60 | $-3.25 |
| Wtd Avg Shares | 0.28B | 0.27B | 0.23B | 0.20B | 0.03B |
| EBITDA | $0.32B | ($0.03B) | ($0.49B) | ($0.44B) | ($0.02B) |
| EBITDA Margin %(computed) | 55.16% | -6.59% | -539.92% | -529.69% | -49.03% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Alvotech
关于Alvotech（ALVO）损益表
Alvotech（ALVO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ALVO实现营收$0.59B，毛利润$0.35B（毛利率59.82%），净利润$0.03B（净利率4.76%）。
常见问题
ALVO · 4 问Alvotech（ALVO）2025财年营收为$0.59B，同比up19.7%。
ALVO revenueALVO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08